HMGB1 and cancer: Administration of DOX increases HMGB1 expression and induces TNF- secretion via TLR4, whereas HMGB1 released from necrotic cancer cells treated with necrosis inducers increases regrowth and metastasis of residual cancer cells through RAGE activation [83,84].